Tadalafil
- Product NDC
- 42291-786
- 11-digit product format
- 422910786
- Labeler code
- 42291
- Product ID
- 42291-786_c7029f7e-68f8-f5a2-e053-2a95a90a368a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tadalafil
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Avkare
- Application
- ANDA090141
- Marketing category
- ANDA
- Marketing start
- 2020-02-04
- Marketing end
- 0000-00-00
- Substance
- TADALAFIL
- Active strength
- 3 mg/1
- Pharmacologic classes
- Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-786-30 | 42291078630 | 30 TABLET, FILM COATED in 1 BOTTLE (42291-786-30) | 2020-02-04 | 0000-00-00 | No | No | Current |